Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|February 1, 1997
The development of antibody delivery systems to target cancer with highly potent maytansinoidsC Liu, R V ChariThe Journal of Biological Chemistry|October 10, 1981
Deuterium isotope effects on the product partitioning of fluoromethylglyoxal by glyoxalase I. Proof of a proton transfer mechanismR V Chari, J W KozarichBiochemistry|January 17, 1984
Purification of the messenger RNA cap-binding protein using a new affinity mediumN R Webb, R V Chari, G DePillis, et al.International Journal of Cancer|December 17, 1997
Folate-maytansinoids: target-selective drugs of low molecular weightC A Ladino, R V Chari, L A Bourret, et al.The Journal of Biological Chemistry|June 10, 1983
13C NMR studies of the product complex of glyoxalase IP R Rosevear, R V Chari, J W Kozarich, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1987
The antileukemic efficacy of an immunotoxin composed of a monoclonal anti-Thy-1 antibody disulfide linked to the ribosome-inactivating protein geloninC F Scott, V S Goldmacher, J M Lambert, et al.Cancer Research|January 1, 1992
Immunoconjugates containing novel maytansinoids: promising anticancer drugsR V Chari, B A Martell, J L Gross, et al.Cancer Research|September 15, 1995
Enhancement of the selectivity and antitumor efficacy of a CC-1065 analogue through immunoconjugate formationR V Chari, K A Jackel, L A Bourret, et al.Proceedings of the National Academy of Sciences of the United States of America|August 6, 1996
Eradication of large colon tumor xenografts by targeted delivery of maytansinoidsC Liu, B M Tadayoni, L A Bourret, et al.Pageof 1